Clinical Trials Directory

Trials / Completed

CompletedNCT06529627

GDF-8 Levels in ICSI Cycles

Effect of Growth Differentiation Factor - 8 (GDF-8) on Pregnancy Rates in GnRH-agonist ICSI Cycles: A Prospective Cohort Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
42 (actual)
Sponsor
University of Alexandria · Academic / Other
Sex
Female
Age
20 Years – 35 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the role of GDF-8 in regulating progesterone levels during controlled ovarian stimulation in patients undergoing ICSI-ET and to evaluate its effects on pregnancy rates. The main questions are * Does serum GDF-8 correlate with serum Progesterone levels during ovarian stimulation? * Does serum GDF-8 serum level at different time-points during ovarian stimulation correlate with pregnancy rate? participants will undergo ICSI-ET cycle using the long GnRH-agonist protocol and serum levels of GDF-8 and progesterone will be measured at three time-points during the trial: on day of hCG trigger administration, on day of oocyte pickup, and 14 days after embryo transfer

Conditions

Interventions

TypeNameDescription
PROCEDURELong Gn-RH agonist protocol - Intracytoplasmic Sperm Injectionpituitary downregulation with GnRH agonist - ovarian stimulation with exogenous gonadotropin - hCG adminstration as trigger of oocyte maturation Oocyte retriveal via transvaginal ultrasound guided aspiration embryo transfer progesterone as luteal phase support

Timeline

Start date
2023-05-01
Primary completion
2023-12-15
Completion
2024-01-31
First posted
2024-07-31
Last updated
2024-07-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06529627. Inclusion in this directory is not an endorsement.

GDF-8 Levels in ICSI Cycles (NCT06529627) · Clinical Trials Directory